Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MicroRNA 1284 (miR-1284) is a short non-coding RNA (20–24 nucleotides) classified as a microRNA, involved in the post-transcriptional regulation of gene expression by binding to target mRNAs, leading to inhibition of translation or mRNA destabilization[2]. miR-1284 has functional roles in the regulation of cell proliferation, apoptosis, and cell cycle progression, particularly in cancer contexts. Experimental studies demonstrate that miR-1284 inhibits growth and induces apoptosis in lung cancer cells, likely through the modulation of key proteins such as Myc, p27, Bax, and caspase-3[1]. Increased miR-1284 levels enhance chemosensitivity, including when co-delivered with cisplatin in experimental systems, suggesting a potential therapeutic target for overcoming drug resistance[4]. As a microRNA, miR-1284 is not a protein-coding gene, enzyme, or receptor, but rather a regulator with broad functional impact in post-transcriptional gene networks[1][2].
Modulation of chemosensitivity via enhancement of apoptosis when co-delivered with chemotherapeutic agents (e.g., cisplatin)[4]
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MicroRNA 1284 (miR-1284).